CXD101
CXD101 is a novel, class I-selective histone deacetylase inhibitor (HDACi) with potent activity against HDAC1, HDAC2, and HDAC3, while exhibiting no inhibition of class II HDACs. This selectivity profile makes it a valuable research tool for investigating epigenetic mechanisms in oncology, with demonstrated utility in both in vitro and in vivo cancer models.
Product Specifications
CAS Number
934828-12-3
Product Name Alternative
Acetylation, antitumor, CXD 101, CXD101, CXD-101, inhibit, orally, Inhibitor, HDAC, HDAC3, HDAC1, HDAC2, Histone deacetylases, histone
Field of Research
Epigenetics & Chromatin, Molecular Biology
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (4.96 mM) ; DMSO:31 mg/mL (76.82 mM)
Smiles
Cc1nn (C) cc1CN1CCC (CC1) c1ccc (cc1) C (=O) Nc1ccccc1N
Molecular Formula
C24H29N5O
Molecular Weight
403.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Rat LEPR (Leptin Receptor) Microsample ELISA Kit
Rat LEPR (Leptin Receptor) Microsample ELISA Kit
